tiprankstipranks
Trending News
More News >
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
Advertisement

Prescient Therapeutics Limited (PTX) Financial Statements

Compare
14 Followers

Prescient Therapeutics Limited Financial Overview

Prescient Therapeutics Limited's market cap is currently AU$45.22M. The company's EPS TTM is AU$-0.006; its P/E ratio is ―; Prescient Therapeutics Limited is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History

Prescient Therapeutics Limited Debt to Assets

Prescient Therapeutics Limited Cash Flow

Prescient Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis